MYTRT launches UK digital testosterone testing and doctor-led hormonal health platform
MYTRT has launched a UK digital healthcare platform offering at-home testosterone testing, biomarker analysis, and doctor-led hormonal health pathways. The move adds to a growing cluster of UK telehealth providers targeting men’s hormone health and TRT assessment.
HORMONAL HEALTHINDUSTRY
Editor
5/28/20261 min read
MYTRT, a UK-based digital healthcare platform, has launched a new service focused on testosterone testing and hormonal health assessment. The platform offers home blood testing combined with clinician review and structured care pathways for patients being evaluated for possible low testosterone.
The service is designed for individuals experiencing symptoms such as fatigue, low mood, reduced libido, and changes in concentration, which may be associated with hormonal imbalance but can also have multiple underlying causes. MYTRT positions its offering as a structured pathway that moves users from initial testing through to clinical interpretation and, where appropriate, further medical assessment.
At the core of the platform is a home blood test that measures testosterone-related biomarkers. Results are reviewed within a clinical workflow rather than being delivered as standalone lab values, with patients offered consultations to discuss results, medical history, and potential treatment options. The company also supports patients already on testosterone replacement therapy (TRT) who wish to transition into a monitored, doctor-led service.
Beyond testosterone, MYTRT also offers broader biomarker testing for general health insights, which can be used in discussions with healthcare professionals or for further clinical review. Treatment decisions are made on an individual basis following consultation and monitoring, with ongoing support framed as part of a longer-term care model.
The launch reflects continued growth in UK digital hormone health services, where private telehealth providers are building end-to-end pathways spanning testing, interpretation, and treatment. MYTRT’s positioning is consistent with a wider trend toward subscription-style, clinician-led men’s health services combining diagnostics with ongoing care management.